ロード中...
Survival in melanoma brain metastases in the era of novel systemic therapies
BACKGROUND: Melanoma brain metastases (MBMs) have historically poor overall survival (OS). Recently introduced systemic anticancer therapies (SACTs), namely targeted therapies such as BRAF inhibitors and immunotherapy, to control advanced disease have shown improved survival. Today, increasingly agg...
保存先:
| 出版年: | Neurooncol Adv |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7764504/ https://ncbi.nlm.nih.gov/pubmed/33392503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa144 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|